Covered recipient · General Payments record
AL RANDY DOYLE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018
$184.07
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $154.08 | 9 |
| Education | $29.99 | 1 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Allergan Inc. | $64.18 | 3 |
| Orexo US, Inc. | $44.06 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.56 | 2 |
| Lundbeck LLC | $22.50 | 1 |
| Indivior Inc. | $13.85 | 1 |
| Teva Pharmaceuticals USA, Inc. | $12.92 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $184.07 | 10 |
Payment records · PY2018 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan Inc. | $29.99 | 03/26/2018 | Education | Undisputed | 01/23/2026 | 596382115 | CMS |
| Allergan Inc. | $19.02 | 03/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 596382137 | CMS |
| Allergan Inc. | $15.17 | 06/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 596382199 | CMS |
| Indivior Inc. | $13.85 | 03/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615457833 | CMS |
| Lundbeck LLC | $22.50 | 01/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567659511 | CMS |
| Orexo US, Inc. | $22.52 | 01/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 605993069 | CMS |
| Orexo US, Inc. | $21.54 | 04/03/2018 | Food and Beverage | Undisputed | 01/23/2026 | 606002815 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $4.90 | 02/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 590084541 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.66 | 04/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 590145061 | CMS |
| Teva Pharmaceuticals USA, Inc. | $12.92 | 04/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | 614117077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.